FDA NDC Directory · JSON-LD · Markdown

Exondys 51

NDC 60923-284 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameeteplirsen
Labeler / ManufacturerSarepta Therapeutics, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA206488
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsETEPLIRSEN (50 mg/mL)
Marketing started20160919
Package count1

External sources

Source: openFDA. Public-domain (CC0).